-
Antipsychotic drugs are the mainstay of treatment of schizophrenia, not only in the event of acute episodes, but also in the long-term perspective. While people might want to stop their treatment at some stage, recurrences of psychotic symptoms are known to occur after treatment discontinuation. Relapses can lead to risk of...
October 27 2020
-
Cochrane is delighted to announce the signing of a new contract with John Wiley & Sons, Ltd. to publish the Cochrane Library for the next 10 years from January 2021. The agreement guarantees major investment into future development of the Library to sustain Cochrane as the world’s pre-eminent collection of high-quality evidence to inform...
October 27 2020
-
Cochrane provides high-quality, relevant, and up-to-date synthesized research evidence to inform health decisions. Content relating to the coronavirus (COVID-19) pandemic and the various activities that Cochrane is undertaking in response can be found here.Cochrane has a broad range of activities available for people who wish to...
October 27 2020
-
We are delighted to announce that the brand new edition of the Cochrane Handbook is now available both online and in print. The Handbook is an essential guide for both new and experienced authors working on Cochrane systematic reviews. It contains a complete overview of the review process from identifying topics in high priority...
October 27 2020
-
Cochrane is inviting applications from people who would like to be ‘Cochrane UK Consumer Champions’.You are welcome to apply if you:have lived experience as a patient or family member/carer for a patient;are based in the UK;have a keen interest in being, or becoming, a consumer advocate in their own area (whether in your local area or for a...
August 11 2020
-
Are psychological interventions effective and safe for adolescents with psychosis? Are there any differences in effect between different psychological interventions? New Cochrane systematic review looks at the available evidence. Click here to find out more.
July 9 2020
-
The 2019 Coronavirus outbreak was declared a global Public Health Emergency by the World Health Organization (WHO) on 30th January 2020.The WHO is now working closely with global experts, governments and partners to rapidly expand scientific knowledge on this new virus, to track the spread and virulence of the virus, and to provide advice to...
March 12 2020
-
Early bird registration is now open for the 2020 Cochrane Colloquium. Register before the 2 July 2020 to receive the reduced early bird rate.Cochrane Colloquium 2020, will be held at the Westin Harbour Castel in Toronto, Canada on the October 4-7, 2020. Click here to find out more.Image Credit: Cochrane.
February 13 2020
-
Is there high-quality evidence indicating that interventions for people at risk of developing psychosis are effective?There has been considerable research effort in this area and several interventions have been trialled. The evidence available suggests that omega-3 fatty acids may prevent transition to psychosis but this evidence is low quality...
November 6 2019
-
An Open Letter in Response to the FDA’s Public Comment Request on the Clinical Data Summary Report Pilot.In January 2018, the FDA announced a pilot aimed at enhancing the transparency of the Agency's drug approval process and decisions...Click here to find out more.Image Credit: pixabay.
September 3 2019
Antipsychotic drugs are the mainstay of treatment of schizophrenia, not only in the event of acute episodes, but also in the long-term perspective. While people might want to stop their treatment at some stage, recurrences of psychotic symptoms are known to occur after treatment discontinuation. Relapses can lead to risk of...October 27 2020
Cochrane is delighted to announce the signing of a new contract with John Wiley & Sons, Ltd. to publish the Cochrane Library for the next 10 years from January 2021. The agreement guarantees major investment into future development of the Library to sustain Cochrane as the world’s pre-eminent collection of high-quality evidence to inform...October 27 2020
Cochrane provides high-quality, relevant, and up-to-date synthesized research evidence to inform health decisions. Content relating to the coronavirus (COVID-19) pandemic and the various activities that Cochrane is undertaking in response can be found here.Cochrane has a broad range of activities available for people who wish to...October 27 2020
We are delighted to announce that the brand new edition of the Cochrane Handbook is now available both online and in print. The Handbook is an essential guide for both new and experienced authors working on Cochrane systematic reviews. It contains a complete overview of the review process from identifying topics in high priority...October 27 2020
Cochrane is inviting applications from people who would like to be ‘Cochrane UK Consumer Champions’.You are welcome to apply if you:have lived experience as a patient or family member/carer for a patient;are based in the UK;have a keen interest in being, or becoming, a consumer advocate in their own area (whether in your local area or for a...August 11 2020
Are psychological interventions effective and safe for adolescents with psychosis? Are there any differences in effect between different psychological interventions? New Cochrane systematic review looks at the available evidence. Click here to find out more.July 9 2020
The 2019 Coronavirus outbreak was declared a global Public Health Emergency by the World Health Organization (WHO) on 30th January 2020.The WHO is now working closely with global experts, governments and partners to rapidly expand scientific knowledge on this new virus, to track the spread and virulence of the virus, and to provide advice to...March 12 2020
Early bird registration is now open for the 2020 Cochrane Colloquium. Register before the 2 July 2020 to receive the reduced early bird rate.Cochrane Colloquium 2020, will be held at the Westin Harbour Castel in Toronto, Canada on the October 4-7, 2020. Click here to find out more.Image Credit: Cochrane.February 13 2020
Is there high-quality evidence indicating that interventions for people at risk of developing psychosis are effective?There has been considerable research effort in this area and several interventions have been trialled. The evidence available suggests that omega-3 fatty acids may prevent transition to psychosis but this evidence is low quality...November 6 2019
An Open Letter in Response to the FDA’s Public Comment Request on the Clinical Data Summary Report Pilot.In January 2018, the FDA announced a pilot aimed at enhancing the transparency of the Agency's drug approval process and decisions...Click here to find out more.Image Credit: pixabay.September 3 2019